BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20859284)

  • 1. A multi-analyte serum test for the detection of non-small cell lung cancer.
    Farlow EC; Vercillo MS; Coon JS; Basu S; Kim AW; Faber LP; Warren WH; Bonomi P; Liptay MJ; Borgia JA
    Br J Cancer; 2010 Oct; 103(8):1221-8. PubMed ID: 20859284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of a multi-analyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer.
    Borgia JA; Basu S; Faber LP; Kim AW; Coon JS; Kaiser-Walters KA; Fhied C; Thomas S; Rouhi O; Warren WH; Bonomi P; Liptay MJ
    J Thorac Oncol; 2009 Mar; 4(3):338-47. PubMed ID: 19190517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.
    Doseeva V; Colpitts T; Gao G; Woodcock J; Knezevic V
    J Transl Med; 2015 Feb; 13():55. PubMed ID: 25880432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood test shows high accuracy in detecting stage I non-small cell lung cancer.
    Goebel C; Louden CL; Mckenna R; Onugha O; Wachtel A; Long T
    BMC Cancer; 2020 Feb; 20(1):137. PubMed ID: 32085733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of lung cancer biomarkers by profiling the plasma proteome with monoclonal antibody libraries.
    Guergova-Kuras M; Kurucz I; Hempel W; Tardieu N; Kádas J; Malderez-Bloes C; Jullien A; Kieffer Y; Hincapie M; Guttman A; Csánky E; Dezso B; Karger BL; Takács L
    Mol Cell Proteomics; 2011 Dec; 10(12):M111.010298. PubMed ID: 21947365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
    Zhu W; Zhou K; Zha Y; Chen D; He J; Ma H; Liu X; Le H; Zhang Y
    PLoS One; 2016; 11(4):e0153046. PubMed ID: 27093275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.
    Yang X; Zhang Q; Zhang M; Su W; Wang Z; Li Y; Zhang J; Beer DG; Yang S; Chen G
    Int J Biol Sci; 2019; 15(8):1712-1722. PubMed ID: 31360113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis.
    Blanco-Prieto S; Barcia-Castro L; Páez de la Cadena M; Rodríguez-Berrocal FJ; Vázquez-Iglesias L; Botana-Rial MI; Fernández-Villar A; De Chiara L
    BMC Cancer; 2017 Dec; 17(1):823. PubMed ID: 29207990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer.
    Xie Y; Zhang Y; Du L; Jiang X; Yan S; Duan W; Li J; Zhan Y; Wang L; Zhang S; Li S; Wang L; Xu S; Wang C
    Mol Oncol; 2018 May; 12(5):648-658. PubMed ID: 29504701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of non-small cell lung cancer.
    Farlow EC; Patel K; Basu S; Lee BS; Kim AW; Coon JS; Faber LP; Bonomi P; Liptay MJ; Borgia JA
    Clin Cancer Res; 2010 Jul; 16(13):3452-62. PubMed ID: 20570928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis Biomarkers May Be Useful in the Management of Patients With Indeterminate Pulmonary Nodules.
    Seder CW; Kubasiak JC; Pithadia R; Basu S; Fhied C; Tarhoni I; Davila E; Alnajjar H; Chmielewski GW; Warren WH; Liptay MJ; Borgia JA
    Ann Thorac Surg; 2015 Aug; 100(2):429-36. PubMed ID: 26138771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum lipidomic biomarkers for non-small cell lung cancer in nonsmoking female patients.
    Noreldeen HAA; Du L; Li W; Liu X; Wang Y; Xu G
    J Pharm Biomed Anal; 2020 Jun; 185():113220. PubMed ID: 32145537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role.
    Wieskopf B; Demangeat C; Purohit A; Stenger R; Gries P; Kreisman H; Quoix E
    Chest; 1995 Jul; 108(1):163-9. PubMed ID: 7541742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of a multianalyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer with circulating autoantibody biomarkers.
    Patel K; Farlow EC; Kim AW; Lee BS; Basu S; Coon JS; DeCresce D; Thimothy L; Walters KA; Fhied C; Chang C; Chen SH; Faber LP; Bonomi P; Liptay MJ; Borgia JA
    Int J Cancer; 2011 Jul; 129(1):133-42. PubMed ID: 20824709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of circulating insulin-like growth factor-associated proteins for the detection of stage I non-small cell lung cancer.
    Kubasiak JC; Seder CW; Pithadia R; Basu S; Fhied C; Phillips WW; Daly S; Shersher DD; Yoder MA; Chmielewski G; Edell ES; Maldonado F; Liptay MJ; Borgia JA
    J Thorac Cardiovasc Surg; 2015 Mar; 149(3):727-34.e1-3; discussion 734. PubMed ID: 25312225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a serum biomarker panel predicting recurrence in stage I non-small cell lung cancer patients.
    Rinewalt D; Shersher DD; Daly S; Fhied C; Basu S; Mahon B; Hong E; Chmielewski G; Liptay MJ; Borgia JA
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1344-50; discussion 1350-1. PubMed ID: 22982029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer.
    Korbakis D; Dimitromanolakis A; Prassas I; Davis GJ; Barber E; Reckamp KL; Blasutig I; Diamandis EP
    Br J Cancer; 2015 Jul; 113(3):484-91. PubMed ID: 26180921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
    Fan J; Yu H; Lv Y; Yin L
    Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum calprotectin, CD26 and EGF to establish a panel for the diagnosis of lung cancer.
    Blanco-Prieto S; Vázquez-Iglesias L; Rodríguez-Girondo M; Barcia-Castro L; Fernández-Villar A; Botana-Rial MI; Rodríguez-Berrocal FJ; de la Cadena MP
    PLoS One; 2015; 10(5):e0127318. PubMed ID: 25992884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.